ʻO Retaglutide kahi dipeptidyl peptidase-4 (DPP-4) inhibitor class hypoglycemic lāʻau lapaʻau hou e hiki ke pale i ka hōʻino ʻana o ka glucagon-like peptide-1 (GLP-1) a me ka glucose-dependent insulin-releasing polypeptide (GIP) e DPP-4 enzyme i loko o ka ʻōpū a me ke koko, e hoʻolōʻihi i kā lākou hana, me ka ʻole o ka hoʻoulu ʻana i ka insulin basalβ i ka pae. e hoʻemi ana i ka huna ʻana o ka glucagon e nā pūnaewele α pancreatic, a laila ʻoi aku ka maikaʻi o ka mālama ʻana i ke kō koko postprandial. Hana maikaʻi ʻo ia ma ke ʻano o ka hopena hypoglycemic, hoʻomanawanui, a me ka hoʻokō.